Fields »
ABOUT
HELP
BLOG

16620 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 333 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
ACOT7Acyl-CoA thioesterase 7
Nucleoplasm
Cytosol		Renal cancer: 2.55e-6
Liver cancer: 2.31e-5
Lung cancer: 1.29e-4
Tissue enhancedcerebral cortex:129.6
ACOT8Acyl-CoA thioesterase 8
Vesicles
Mitochondria		Renal cancer: 3.18e-4
Expressed in all
ACOT9Acyl-CoA thioesterase 9
Nucleoplasm
Plasma membrane
Cytosol		Liver cancer: 3.23e-4
Expressed in all
ACOX1Acyl-CoA oxidase 1, palmitoyl
Nucleus
Vesicles		Renal cancer: 5.25e-7
Expressed in all
ACOX2Acyl-CoA oxidase 2, branched chain
Vesicles
Mitochondria		Tissue enhancedliver:87.8
ACOX3Acyl-CoA oxidase 3, pristanoyl
PeroxisomesEndometrial cancer: 2.16e-4
Expressed in all
ACOXLAcyl-CoA oxidase-like
N/A
Nucleoli
Cytosol		Urothelial cancer: 6.48e-4
Group enriched5epididymis:9.2
lung:14.6
parathyroid gland:7.4
prostate:5.5
testis:5.3
urinary bladder:8.0
ACP1Acid phosphatase 1, soluble
Nucleus
Cytosol		Liver cancer: 6.67e-6
Melanoma: 3.04e-4
Expressed in all
ACP5Acid phosphatase 5, tartrate resistant
CytosolTissue enhancedlung:254.2
ACP6Acid phosphatase 6, lysophosphatidicN/A
Urothelial cancer: 6.44e-4
Expressed in all
ACPPAcid phosphatase, prostate
Tissue enriched153prostate:6368.2
ACRAcrosin
Tissue enriched56testis:115.9
ACRBPAcrosin binding protein
Nucleoplasm
Vesicles		Tissue enriched19testis:432.6
ACRCAcidic repeat containing
VesiclesGroup enriched5adrenal gland:5.9
testis:20.6
ACRV1Acrosomal vesicle protein 1
Tissue enriched37testis:152.8
ACSBG1Acyl-CoA synthetase bubblegum family member 1
VesiclesTissue enhancedcerebral cortex:25.7
skin:13.3
ACSBG2Acyl-CoA synthetase bubblegum family member 2
CytosolTissue enriched709testis:291.8
ACSF2Acyl-CoA synthetase family member 2
Nucleoplasm
Microtubules
Cytosol		Renal cancer: 2.17e-4
Urothelial cancer: 2.41e-4
Tissue enhancedkidney:136.1
ACSL1Acyl-CoA synthetase long-chain family member 1
Nucleus
Mitochondria		Renal cancer: 1.25e-5
Expressed in all
ACSL3Acyl-CoA synthetase long-chain family member 3
Nucleoli
Lipid droplets		Liver cancer: 2.75e-4
Lung cancer: 8.78e-4
Expressed in all
ACSL4Acyl-CoA synthetase long-chain family member 4
Golgi apparatus
Mitochondria		Urothelial cancer: 5.73e-4
Expressed in all
ACSL5Acyl-CoA synthetase long-chain family member 5
Nucleus
Mitochondria		Endometrial cancer: 1.13e-4
Expressed in all
ACSL6Acyl-CoA synthetase long-chain family member 6
Group enriched6bone marrow:18.0
cerebral cortex:62.1
parathyroid gland:22.1
seminal vesicle:28.7
testis:51.2
ACSM1Acyl-CoA synthetase medium-chain family member 1N/A
Tissue enriched55breast:293.3
ACSM2AAcyl-CoA synthetase medium-chain family member 2A
Liver cancer: 1.41e-5
Group enriched578kidney:284.3
liver:185.7
ACSM2BAcyl-CoA synthetase medium-chain family member 2B
Liver cancer: 3.31e-4
Group enriched85kidney:423.8
liver:261.6
ACSM3Acyl-CoA synthetase medium-chain family member 3
Renal cancer: 9.88e-6
Ovarian cancer: 1.97e-4
Tissue enhancedliver:93.0
ACSM4Acyl-CoA synthetase medium-chain family member 4N/A
Tissue enhancedovary:2.5
testis:2.6
ACSM5Acyl-CoA synthetase medium-chain family member 5
Tissue enhancedliver:142.5
ACSM6Acyl-CoA synthetase medium-chain family member 6N/A
Urothelial cancer: 7.71e-4
Tissue enhancedstomach:1.7
ACSS1Acyl-CoA synthetase short-chain family member 1
Lung cancer: 8.33e-5
Cervical cancer: 9.37e-4
Expressed in all
ACSS2Acyl-CoA synthetase short-chain family member 2
Nucleoplasm
Vesicles
Cytosol		Renal cancer: 2.04e-4
Mixed
ACSS3Acyl-CoA synthetase short-chain family member 3
MitochondriaRenal cancer: 0.00e+0
Mixed
ACTA1Actin, alpha 1, skeletal muscle
Tissue enriched18skeletal muscle:45988.0
ACTA2Actin, alpha 2, smooth muscle, aorta
Renal cancer: 1.37e-8
Expressed in all
ACTBActin, beta
Renal cancer: 3.78e-5
Head and neck cancer: 4.51e-4
Expressed in all
ACTBL2Actin, beta-like 2N/A
Not detected
ACTC1Actin, alpha, cardiac muscle 1
Actin filamentsHead and neck cancer: 3.72e-5
Urothelial cancer: 9.32e-4
Tissue enriched11heart muscle:2123.3
ACTG1Actin gamma 1
Colorectal cancer: 2.41e-4
Expressed in all
ACTG2Actin, gamma 2, smooth muscle, enteric
Renal cancer: 3.95e-7
Tissue enhancedseminal vesicle:8064.0
smooth muscle:11485.7
ACTL6AActin-like 6A
Nucleoplasm
Cytosol		Liver cancer: 1.89e-5
Renal cancer: 4.80e-5
Pancreatic cancer: 5.44e-5
Expressed in all
ACTL6BActin-like 6BN/A
NucleoliTissue enriched19cerebral cortex:45.7
ACTL7AActin-like 7A
Tissue enriched1933testis:193.2
ACTL7BActin-like 7B
Tissue enriched593testis:59.3
ACTL8Actin-like 8
CytosolEndometrial cancer: 1.62e-6
Head and neck cancer: 7.02e-4
Tissue enriched34testis:10.0
ACTL9Actin-like 9N/A
Tissue enriched502testis:50.2
ACTN1Actinin, alpha 1
Plasma membrane
Focal adhesion sites		Renal cancer: 9.08e-10
Lung cancer: 7.63e-5
Head and neck cancer: 2.49e-4
Urothelial cancer: 8.00e-4
Expressed in all
ACTN2Actinin, alpha 2
Group enriched27heart muscle:461.7
skeletal muscle:758.8
ACTN3Actinin, alpha 3 (gene/pseudogene)N/A
Tissue enriched119skeletal muscle:556.7
ACTN4Actinin, alpha 4
Nuclear bodies
Cytosol		Renal cancer: 5.25e-5
Pancreatic cancer: 5.65e-4
Lung cancer: 8.82e-4
Expressed in all

« prev | Page of 333 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.